TCL Archive Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable April 26, 2013
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship July 23, 1999
TCL Archive In Brief: Edward Sondik Named Director Of CDC’s National Center for Health Statistics April 12, 1996
TCL Archive Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel May 31, 2002
TCL Archive After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant June 11, 2014
